We are grateful for the comment on our study.1 We are pleased to know that short chain fatty acids (SCFA), especially butyrate, in the intestine could stimulate the colonization of curli-producing Escherichia coli (E. coli). Curli are functional amyloids produced by gut microbes and act as cross-beta-sheet amyloid polymers to assist bacterial cells in binding to one another to form biofilm.2 Curli participates in the intracellular self-assembly process of pathological human amyloids, including α-synuclein, leading to proteopathy and the promotion of intestinal inflammation through toll-like receptors (TLRs), or mapranosis.3 A study implanting curli-producing E. coli in germ-free α-synuclein overexpressing mice resulted in α-synuclein aggregations and neuroinflammation, with an increased expression of tumor necrosis factor alpha (TNF α).4 These Parkinson’s disease (PD)-like neuropathology were reversed in mice colonized with a curli-deficient E. coli strain, supporting that gut microbial amyloids can exacerbate gut and neuropathology of PD.4 These observations are compatible with recent evidence that intestinal inflammation promotes PD neuropathology through activating toll-like receptors (TLRs) and tumor necrosis factor alpha (TNFα)-mediated neuroinflammation.5 Furthermore, there are many members of the microbiome capable of producing function amyloids, including Klebsiella species, for which abundance has a positive correlation between the plasma butyrate level in PD patients in our study.1 SCFAs may play a pivotal role in the gut-brain communication of the PD process. CLICK TO REVIEW